Published

Former J&J Attorney and Current Kalderos Board Director Says Battle over Rebates Has Not Ended - 340B Report

Summary by 340breport.com
An influential drug industry expert said that he expects Johnson & Johnson to sue the government over its refusal to approve the drug giant’s controversial plan to change the 340B program from an upfront discount to a back-end rebate.  The remarks, from an attorney who used to represent Johnson & Johnson (J&J) in private practice, occurred during a panel discussion on hot button legal issues at the Association for Value-Based Cancer Care Annual …
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.